NCT07426874

Brief Summary

This study evaluates the development, implementation and effectiveness of a nurse-led eHealth support tool designed to improve quality of life and survivorship outcomes among adults treated for head and neck cancer. The intervention integrates symptom monitoring, self-management education, and structured survivorship support into routine follow-up care. Outcomes will include patient-reported quality of life, symptom burden, and healthcare utilization.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
6mo left

Started Sep 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress59%
Sep 2025Dec 2026

Study Start

First participant enrolled

September 1, 2025

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

February 16, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 23, 2026

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 12, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

February 23, 2026

Status Verified

February 1, 2026

Enrollment Period

1.1 years

First QC Date

February 16, 2026

Last Update Submit

February 16, 2026

Conditions

Head and Neck Cancer (H&N)

Keywords

Head and Neck Cancer

Outcome Measures

Primary Outcomes (1)

  • Quality of Life EORTC QLQ-C30 (Global Health Status scale)

    Measurement Tool: EORTC QLQ-C30 (Global Health Status scale) Time Frame: Baseline, 3 months, 6 months

    Baseline, 3 months, 6 months

Study Arms (2)

Intervention

EXPERIMENTAL

Intervention Name: eHealth Survivorship Support Tool Description: A digital platform including: Symptom monitoring Educational modules Self-management guidance Nurse-supported remote follow-up

Other: eHealth Survivorship Support Tool

Control

ACTIVE COMPARATOR

Participants receive standard survivorship follow-up as per institutional guidelines.

Other: Control

Interventions

eHealth Survivorship Support ToolOTHER

A digital platform including: Symptom monitoring Educational modules Self-management guidance Nurse-supported remote follow-up

Intervention
ControlOTHER

Standard follow up

Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults ≥18 years Diagnosed with head and neck cancer Completed primary treatment (surgery, radiotherapy, chemotherapy or combination) Within 12 months post-treatment Access to smartphone/tablet/internet Able to provide informed consent

You may not qualify if:

  • Recurrent or metastatic disease requiring active treatment Significant cognitive impairment Inability to use digital device Non-English speakers (if tool not multilingual)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beaumont RCSI Cancer Centre

Beaumont, D09V2N0, Ireland

Location

MeSH Terms

Conditions

Head and Neck Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 16, 2026

First Posted

February 23, 2026

Study Start

September 1, 2025

Primary Completion (Estimated)

October 12, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

February 23, 2026

Record last verified: 2026-02

Locations

IE(1)